Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Beat The Street With SI Traders -- Ignore unavailable to you. Want to Upgrade?

To: calgarylady who wrote (210083)	3/8/2021 10:44:26 AM
From: Rocket Red	1 Recommendation Recommended By calgarylady Respond to of 233883

ya i don't have it listed for some reason

To: calgarylady who wrote (210083)	3/8/2021 6:48:51 PM
From: Rocket Red	1 Recommendation Recommended By calgarylady Respond to of 233883

Leveljump Healthcare Corp (C-JUMP) - Warrants Called to TradeLeveljump Healthcare warrants to trade on TSX-V 2021-03-08 18:06 ET - Warrants Called to Trade Shares issued 40,489,400 JUMP Close 2021-03-08 C$ 0.335 Effective at the opening, Wednesday, March 10, 2021, the common share purchase warrants of the company will commence trading on the TSX Venture Exchange. The company is classified as a medical and diagnostic laboratory company. Corporate jurisdiction: federal Capitalization: up to 10,507,663 warrants created and authorized, of which 9,811,622 are issued and outstanding Escrow: 833,333 warrants subject to escrow Transfer agent: TSX Trust Company Trading symbol: JUMP.WT Cusip No.: 52731E 11 4 Further to the exchange bulletin dated Dec. 10, 2020, these warrants were issued under a warrant indenture dated Oct. 30, 2020, and supplement to warrant indenture dated Nov. 25, 2020, pursuant to a brokered private placement offering completed prior to the completion of the company's qualifying transaction. Each warrant entitles the holder to purchase one common share of the company at a price of 50 cents until Dec. 14, 2023. For further details, please refer to the company's news releases dated Feb. 4, 2021 and March 8, 2021.